Cytodyn Inc 's

• CYDY's Stock Performance relative to its Competitors

Werewolf Therapeutics Inc Share Performance -4.77% Over The Past 5 Days

Werewolf Therapeutics Inc Profile Werewolf Therapeutics Inc operates with a business model focused on utilizing innovative technologies to develop therapies targeting cancer using immune cell activation. More about Werewolf Therapeutics Inc 's Market Share

Innoviva Inc Share Performance +0.33% Over The Past 5 Days

Innoviva Inc Profile Innoviva Inc's business model revolves around the development and commercialization of pharmaceutical products. The company primarily focuses on creating strategic collaborations and partnerships with biopharmaceutical companies to advance innovative therapies. Innoviva generates revenue through royalty payments received based on the sales of its partnered products. More about Innoviva Inc 's Market Share

Atea Pharmaceuticals Inc Share Performance +14.70% This Quarter

Atea Pharmaceuticals Inc Profile Atea Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing antiviral therapeutics to combat infectious diseases. Their business model revolves around identifying and advancing novel drug candidates that target specific viral mechanisms and inhibit their replication. This includes conducting preclinical and clinical trials, engaging in strategic partnerships, and ultimately bringing effective antiviral treatments to market. More about Atea Pharmaceuticals Inc 's Market Share

Annovis Bio Inc Share Performance -71.51% This Year

Annovis Bio Inc Profile Annovis Bio Inc's business model revolves around developing novel therapeutics to treat neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and ALS (amyotrophic lateral sclerosis). They focus on identifying and targeting multiple disease pathways simultaneously to address the complex nature of these disorders. More about Annovis Bio Inc 's Market Share

Medicinova Inc Share Performance +106.56% One Year

Medicinova Inc Profile Medicinova Inc operates under a biopharmaceutical business model, primarily focused on the development and commercialization of innovative therapeutics. They strive to identify promising drug candidates with the potential to address unmet medical needs and advance them through clinical trials. By leveraging their research capabilities, strategic partnerships, and licensing opportunities, Medicinova Inc aims to bring these novel treatments to market and improve patient outcomes. More about Medicinova Inc 's Market Share

Sources: Cytodyn inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 15, 2026 7:24 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Cytodyn inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.